We are live on ! Find out more
NEO icon

NeoGenomics

239 hedge funds and large institutions have $956M invested in NeoGenomics in 2022 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 93 increasing their positions, 71 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

227% more call options, than puts

Call options by funds: $4.51M | Put options by funds: $1.38M

31% more repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 71

4.07% more ownership

Funds ownership: 89.99%94.06% (+4.1%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

14% less funds holding

Funds holding: 279239 (-40)

30% less capital invested

Capital invested by funds: $1.36B → $956M (-$404M)

54% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 65

Holders
239
Holders Change
-40
Holders Change %
-14.34%
% of All Funds
4.01%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
30
Increased
93
Reduced
71
Closed
65
Calls
$4.51M
Puts
$1.38M
Net Calls
+$3.13M
Net Calls Change
+$1.93M

NEO Hedge Fund Activity: Q2 2022 in Review

239 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q2 2022, worth a combined $956M — down 30% from $1.36B a quarter earlier.

Sellers outnumbered buyers: 65 funds closed out of NEO and 30 opened new positions — a net loss of 35 holders — while 71 trimmed existing stakes and 93 added.

The largest buyer was Assenagon Asset Management, adding an estimated $33.9M. The largest seller was Artisan Partners, exiting entirely with an estimated $61.8M sold.

  • 239 institutional investors held NeoGenomics (NEO) as of Q2 2022, down from 279 in Q1 2022.
  • Funds reported $956M of NeoGenomics stock for Q2 2022, down 30% quarter-over-quarter.
  • 30 funds opened new NeoGenomics positions in Q2 2022 and 65 closed out, a net change of -35 holders.
  • The largest NeoGenomics buyer in Q2 2022 was Assenagon Asset Management, an estimated $33.9M added.
  • The largest NeoGenomics seller in Q2 2022 was Artisan Partners, an estimated $61.8M sold.

Based on aggregated 13F filings for Q2 2022.